Prevalence of bruxism in children receiving treatment for attention deficit hyperactivity disorder: a pilot study.
The objective of this study was to evaluate reported bruxism among children affected by attention deficit hyperactivity disorder (ADHD). Thirty children diagnosed with ADHD and 30 healthy age and gender matched controls participated in the study. All subjects were examined for dental attrition, and the parents were asked for signs and symptoms of bruxism in their children using a questionnaire. Prevalence of oral parafunction was evaluated comparing ADHD children taking medications, ADHD children not taking medications, and controls. Subjects affected by ADHD and pharmacologically treated showed higher occurrence of bruxism compared to subjects affected by ADHD not taking medicines and controls; and within the ADHD group taking medications, CNS-stimulants have been associated with such side effect more frequently than the other drugs.
Malki
Ghadah A
GA
Dental Center, King Fahad Hospital, Jeddah, Saudi Arabia.
Zawawi
Khalid H
KH
Melis
Marcello
M
Hughes
Christopher V
CV
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000704:Analysis of Variance; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications* / Q000188:drug therapy*; D002012:Bruxism / Q000150:complications / Q000209:etiology*; D016022:Case-Control Studies; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D018492:Dopamine Antagonists / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D010865:Pilot Projects; D012044:Regression Analysis; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects; D011795:Surveys and Questionnaires; D014072:Tooth Abrasion / Q000209:etiology
D000317:Adrenergic alpha-Antagonists; D000697:Central Nervous System Stimulants; D018492:Dopamine Antagonists; D017367:Selective Serotonin Reuptake Inhibitors